St. Jude Medical Reports Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Canaccord Genuity Cuts Price Target on St. Jude Medical (STJ) Following In-Line 3Q Results
October 22, 2015 10:09 AM EDTCanaccord Genuity maintained a Sell rating on St. Jude Medical (NYSE: STJ), and cut the price target to $59.00 (from $64.00), following the company's 3Q15 earnings results. While Q3 top- and bottom-line performance was largely in line with expectations, there was notable weakness in several key... More
Stifel Downgrades St. Jude Medical (STJ) to Hold
October 22, 2015 7:08 AM EDTStifel downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold and removed its price target (prior $89.00).
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $62.30 yesterday.
... MoreSt. Jude Medical (STJ) Reports In-Line Q3 EPS
October 21, 2015 7:17 AM EDTSt. Jude Medical (NYSE: STJ) reported Q3 EPS of $0.97, in-line with the analyst estimate of $0.97. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.35 billion.
St. Jude Medical sees Q4 2015 EPS of $1.00-$1.02, versus the consensus of... More
